| Literature DB >> 18178295 |
Shin Onodera1, Shigeki Oshima, Jun Nishihira, Kazunori Yasuda, Harukazu Tohyama, Kazuharu Irie, Yoshikazu Koyama.
Abstract
Previous studies have demonstrated that mice deficient in the macrophage migration inhibitory factor (MIF) gene are protected from ovariectomy (OVX)-induced bone loss. We developed a novel MIF-deoxyribonucleic acid (DNA) vaccine by introducing oligonucleotides encoding a helper T epitope into the cDNA sequence of murine MIF. Mice given the MIF-DNA vaccine produced high titers of autoantibody against MIF, and were protected from OVX-induced bone loss. Our results further support the hypothesis that MIF is involved in the pathomechanism of OVX-induced bone loss, and also show that active immunization against MIF using a DNA vaccine may be useful for the prophylactic treatment of postmenopausal osteoporosis.Entities:
Mesh:
Substances:
Year: 2007 PMID: 18178295 DOI: 10.1016/j.vaccine.2007.11.066
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641